Moving Forward Poster Trilogy at the EHDN2022 Bologna Meeting – Written by the Moving Forward Team on October 17th, 2022 Photo 1. Filipa and Ruth…
CIEHNCIA: UNCOMPLICATING RESEARCH FOR THE HUNTINGTON COMMUNITY The 2nd Moving Forward Meeting in Spain – Written by the Moving Forward Team on October 13th 2022…
Prilenia Phase 3 Trial with Pridopidine – Why is it Different? – Written by the Moving Forward team on September 12th, 2022 For all those…
UniQure: the Highs and Lows of AMT-130 – Written by the Moving Forward team on September 9th 2022 UniQure is a company with an expertise…
PIVOT-HD, PTC Therapeutics Phase 2 Trial to Lower Huntingtin – Written by the Moving Forward team on September 8th, 2022 PTC Therapeutics is a US…
Suspending is not Ending: Updates about the Novartis VIBRANT-HD trial – Written by the Moving Forward team on September 8th 2022 At the end of…
Online Conversation (in Spanish) with French Adventurer Dimitri Poffé – Written by the Moving Forward team on August 1st, 2022 Last June, our Project Coordinator in…
The Moving Forward “Let Us Talk” work was among the top scoring presentations at the European Conference on Rare Diseases & Orphan Products – Written…
Moving Forward presents E-Poster at the Congress of the European Academy of Neurology – Written by the Moving Forward Team on July 16th 2022 At…
Moving Forward does “De Ronde” – Written by the Moving Forward Team on July 16th 2022 Photo 1. Filipa and Bea “De Ronde” is one…